CORDIS
EU research results

CORDIS

English EN

A portable device for Early detection and treatment of Traumatic Brain Injury based on advanced qEEG and HD-TES to prevent major Health problems and specially for use in emergencies and telemedicine

Project information

Grant agreement ID: 605103

Status

Closed project

  • Start date

    1 October 2013

  • End date

    30 September 2015

Funded under:

FP7-SME

  • Overall budget:

    € 1 499 989,40

  • EU contribution

    € 1 187 000

Coordinated by:

SMARTBRAIN AS

Norway

Objective

Traumatic Brain Injury (TBI) is recognized as a major public health concern, especially for teenagers and young adults, since it can lead to significant disruption in education, working ability, and quality-of-life in general. It is one of the leading causes of death and disability worldwide. 1.2 million EU citizens are hospitalized with TBI each year and of which 50.000 die. The total economic burden in Europe for TBI of all known severities is estimated EUR 33 billion annually. Currently, there is no objective method for diagnosing TBI in an early stage or in emergency, which is a premise to prevent serious health impact. Our idea is to develop a portable medical device for objective and reliable emergency diagnosis of TBI and a monitored personalized treatment based on qEEG (quantitative electroencephalography) and HD-TES (High-Definition Transcranial Electric Stimulation). We propose to create innovative technology for the early detection and treatment of one of the most severe cognitive diseases for the use in emergency, telemedicine, hospitals, and rehabilitation centers. We will achieve this by 1) developing a novel vacuum based helmet device that will enable an accurate positioning system of up to 32 electrodes, 2) developing an instrumentation system that will combine qEEG recording and HD
-TES treatment, 3) developing a data processing system that will control all measurements and data analysis including the algorithm for early detection and treatment of TBI. Our innovation will increase quality-of-life, improve first-aid care, and healthcare in remote and rural areas. Moreover, the society will benefit from sustainable savings in costs for healthcare and for work disability. We, the SMEs, will benefit from increased revenue and sales of the developed technologies and expect 5 year post-project an accumulated revenue of € 125 million and creating and estimated 833 jobs.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

SMARTBRAIN AS

Address

Dronningens Gate 16
0152 Oslo

Norway

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 497 507,25

Administrative Contact

Haldor Sjaaheim (Mr.)

Participants (7)

neuroConn GmbH

Germany

EU Contribution

€ 227 459

PRIMASIL SILICONES LIMITED

United Kingdom

EU Contribution

€ 211 663,75

MEYTEC GmbH Informationssysteme

Germany

EU Contribution

€ 181 936

UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS

Germany

EU Contribution

€ 40 496

STIFTELSEN SINTEF

Norway

EU Contribution

€ 15 895

TALLINNA TEHNIKAULIKOOL

Estonia

EU Contribution

€ 3 936

CARDIFF UNIVERSITY

United Kingdom

EU Contribution

€ 8 107

Project information

Grant agreement ID: 605103

Status

Closed project

  • Start date

    1 October 2013

  • End date

    30 September 2015

Funded under:

FP7-SME

  • Overall budget:

    € 1 499 989,40

  • EU contribution

    € 1 187 000

Coordinated by:

SMARTBRAIN AS

Norway